written on 10.04.2014

WARNING: Capital formation measures may have unintended consequences


Seven new legislative proposals intended to ease US securities regulations on small and emerging growth companies (EGCs), like many biotechs, are a piecemeal attempt at tweaking current law and lack any consistent vision, said John Coffee, a professor at…